Sarah E Ackermann

5PUBLICATIONS

116CO-AUTHORS

Molecular targets

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|Jul 09, 2026

Acquisition of resistance to RAS inhibition is associated with the upregulation of macropinocytosis through both PI3K-dependent and -independent signaling.

|Jun 26, 2026

Patient-derived organoids across cancers reveal conserved tumor heterogeneity and actionable therapeutic vulnerabilities.

|Nov 17, 2025

CRISPR-Cas9 Screening Identifies Resistance Mechanisms to KRAS Inhibition in Pancreatic Cancer.

Szu-Aun Long, Haley Todd, Grace Goodhart

|Feb 11, 2025

Concurrent Inhibition of the RAS-MAPK Pathway and PIKfyve Is a Therapeutic Strategy for Pancreatic Cancer.

Jonathan M DeLiberty, Mallory K Roach, Clint A Stalnecker

|Feb 01, 2025

Kinome-Focused CRISPR-Cas9 Screens in African Ancestry Patient-Derived Breast Cancer Organoids Identify Essential Kinases and Synergy of EGFR and FGFR1 Inhibition.

Florencia P Madorsky Rowdo, Rachel Martini, Sarah E Ackermann

Pageof 1

Frequent Collaborators

Clint A Stalnecker

Adrienne D Cox

Kirsten L Bryant

Olivier Elemento

John Nguyen

Juan Miguel Mosquera

Marvel Tranquille

Florencia P Madorsky Rowdo

2 joint publications

Michael Sigouros

2 joint publications

Adriana Irizarry

Frequent Collaborators

Clint A Stalnecker

Adrienne D Cox

Kirsten L Bryant

Olivier Elemento